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ABSTRACT    The Uukuniemi virus  (UUKV)  is  a member of  the Bunyaviridae  family  (genus 












1. REVIEW OF THE LITERATURE  






1.2 Family Bunyaviridae  
1.2.1 Classification   The  family Bunyaviridae  is  a  large  and  diverse  virus  family  containing many important animal and plant viruses with trisegmented, negative‐strand RNA genomes (Schmaljohn  &  Nichol,  2007;  Bouloy,  2011).  The  majority  of  these  viruses  are transmitted by arthropods, such as mosquitoes and ticks. Bunyaviruses are classified as  emerging  viruses  due  to  their  increased  incidence  in  new  geographical  locations and populations throughout the world (Walter & Barr, 2011). The first member of the family was originally isolated from Aedes mosquitoes in Uganda during a yellow fever study in 1943 by Smithburn and colleagues (reviewed in  Schmaljohn  &  Nichol,  2007).  This  prototype  species  of  the  family,  Bunyamwera virus, led to the discovery of a new family of viruses. In the following decades several new members were found, leading to the establishment of the family Bunyaviridae in 1975 to encompass this  large group of mainly arthropod‐borne viruses, which share the same morphological, morphogenic and antigenic properties (Plyusnin et al., 2011). The Bunyaviridae  family was originally  defined  as  a  single Bunyavirus  genus, containing 150 viruses and 87 tentative viruses (Murphy et al., 1973; Porterfield et al., 1975). Based on antigenic, genetic and ecological relatedness, the family was further divided into four genera in 1980 (Bishop et al., 1980). Today, the family Bunyaviridae contains  more  than  350  viruses  classified  into  five  genera:  Orthobunyavirus, 















Phlebovirus       
    Rift Valley fever virus           Rift Valley fever virus  (RVFV)  Mosquito   Africa, Arabian peninsula  Human: Hemorrhagic fever, encephalitis Domestic ruminants: necrotic hepatitis, hemorrhage, abortion 
    Sandfly fever Naples virus           Toscana virus (TOSV)  Phlebotomine fly (sandfly)  Mediterranean countries, Africa  Human: Febrile illness (Sandfly fever)     Sandfly fever Naples virus  Phlebotomine fly(sandfly)  Mediterranean countries, Africa  Human: Febrile illness (Sandfly fever) 
    Uukuniemi virus           Uukuniemi virus (UUKV)  Tick  Europe  ‐  
Nairovirus       
    Crimean–Congo hemorrhagic fever virus         Crimean–Congo hemorrhagic fever  virus (CCHFV)  Tick, culicoid fly  Eastern Europe, Africa, Asia  Human: Hemorrhagic fever  
    Nairobi sheep disease virus           Nairobi sheep disease 
virus (NSDV)  Tick, culicoid fly, mosquito  Africa, Asia  Sheep, goat: Hemorrhagic gastroenteritis, abortion  
Orthobunyavirus       
    Bunyamwera virus           Bunyamwera virus (BUNV)  Mosquito  Africa  Human: Febrile illness 
    California encephalitis virus           La Crosse virus (LACV)  Mosquito  North America  Human: Encephalitis, meningitis     Inkoo virus (INKV)  Mosquito  Europe  Human: Febrile illness 
    Oropouche virus           Oropouche virus (OROV)  Mosquito, culicoid fly    South America  Human: Febrile illness  
Hantavirus           Puumala virus (PUUV)  Bank vole  Western Europe, Asia  Human: HFRS  (Mild form, NE)     Hantaan virus (HTNV)  Field mouse  Asia  Human: HFRS      Sin Nombre virus (SNV)  Deer mouse  North America  Human:HCPS     Andes virus (ANDV)  Long‐tailed pygmy rice rat  South America  Human:HCPS     Thottapalayam virus (TPMV)  Asian house shrew  South Asia and East Africa   Not known 
Tospovirus       






1.2.2 Epidemiology and transmission   All  members  of  the  Bunyaviridae  family  were  earlier  called  arboviruses (arthropod‐borne  animal  viruses)  according  to  their  most  common  transmitting vectors, arthropods (Schmaljohn & Nichol, 2007). Bunyaviruses, with the exception of hantaviruses,  replicate  mostly  in  their  arthropod  hosts,  such  as  mosquitoes, phlebotomine  flies,  ticks  and  thrips.  Three  arbovirus  genera,  Orthobunyavirus, 
Phlebovirus,  and  Nairovirus  are  able  to  alternately  replicate  in  vertebrates  and arthropods (Plyusnin et al., 2011). Orthobunyaviruses form the largest genus in the Bunyaviridae family with over 170  known  viruses.  The  majority  of  these  viruses  are  transmitted  by  mosquitoes (Elliott & Blakqori, 2011). The viruses in the Phlebovirus genus by contrast are mostly transmitted by sandflies (Phlebotomus spp.). Although the sandflies are the principal vectors, phleboviruses are also transmitted by ticks, e.g. the UUKV, and by mosquitoes, e.g.  the  Rift  Valley  fever  virus  (RVFV)  (Bouloy,  2011).  Nairoviruses  are  mostly transmitted by  ticks, while  the plant‐infecting members of  the Tospovirus  genus are known  to  be  transmitted  only  by  thrips  (Schmaljohn & Nichol,  2007; Bouloy,  2011; Kormelink, 2011). The genus Hantavirus is an exception within the family, since these viruses  are  not  transmitted  by  arthropods.  Earlier  rodents  were  the  only  known reservoir  for  hantaviruses,  but  lately  the majority  of  novel  hantaviruses  have  been isolated  from insectivores (Schmaljohn & Nichol, 2007; Sironen and Plyusnin, 2011) (Table 1).  






bunyaviruses that infect humans cause relatively mild febrile illnesses and are rarely fatal  (Elliott,  1990).  In  addition  to  human  disease,  the  bunyaviruses  cause  severe animal and plant diseases, with high mortality rates among infected livestock and thus have a great economic impact due to crop losses (Elliott, 1990). In  the  genus Orthobunyavirus,  at  least  30  viruses  have  been  associated with human disease,  such as  febrile  illness,  encephalitis  and hemorrhagic  fever  (Elliott & Blakqori, 2011). The Nairovirus  genus contains some serious pathogens,  such as  the CCHFV  and  Nairobi  sheep  disease  virus.  CCHFV  can  cause  hemorrhagic  disease  in humans, with mortality rates of up to 50%, whereas the Nairobi sheep disease virus causes  severe  gastroenteritis  in  sheep  and  goats,  with  mortality  rates  up  to  90% (Honig et al., 2004). Many other nairoviruses are associated with disease in humans. These  include  the Dugbe virus  (DUGV), which can cause  thrombocytopenia  (Bouloy, 2011).  Hantaviruses  are  globally  distributed  emerging  pathogens,  which  can  cause severe  disease  in  humans  (Vaheri  et  al.,  2011).  In  rodent  and  insectivore  hosts, hantaviruses  establish  a  persistent  infection,  whereas  in  humans  they  can  cause severe diseases called hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS). Hantaviruses can be divided into two groups: the Old World  hantaviruses,  which  cause  HFRS with mortality  rates  of  1‐15%,  and  the New  World  hantaviruses,  which  cause  HCPS  with  mortality  rates  up  to  40% (Spiropoulou,  2011).  Tospoviruses  are  distributed worldwide  and  are  able  to  infect various agriculturally and horticulturally important crops (Kormelink, 2011).  
1.3 Genus Phlebovirus   The name of the genus Phlebovirus derives from the phlebotomine flies, which are the vectors of the sandfly fever group of viruses: the Greek word phlebos means "vein"  (Schmaljohn  &  Nichol,  2007).  The  two  genera  of  sandflies,  Phlebotomus  and 


















Culicoides midges  have been  suggested  as  the  vector.  The  virus  is  closely  related  to known orthobunyaviruses,  the Akabane and Shimane viruses, which  can  cause mild disease  in  ruminants.  The  infection  may  lead  to  abortions  and  malformations  in offspring.  Now  there  are  reports  of  increased  abortions  and  malformations  in newborn ruminants in several European countries, and the virus have been identified in deformed lambs (Bilk et al., 2012). It is unlikely that the SBV causes human disease, although  it  cannot  be  excluded  yet  (ECDC,  2011),  and more  cases  in  livestock  will probably emerge this year (Veterinary Record, 2012).  
1.3.2 Discovery of Uukuniemi virus (UUKV)   The  Uukuniemi  virus  (UUKV),  a  member  of  the  Phlebovirus  genus,  was originally  isolated  from  Ixodes  ricinus  ticks  in  Uukuniemi,  South‐Eastern  Finland  in 1959  (Oker‐Blom  et  al.,  1964).  Characterization  of  the  prototype  strain  S23  in  the early 1970s revealed a novel virus structure with four structural proteins (Pettersson 
et al., 1971; von Bonsdorff & Pettersson, 1975) and a segmented, single‐stranded RNA genome (Pettersson & Kääriäinen, 1973). The proteins were identified as two surface glycoproteins Gn and Gc (originally named G1 and G2) (von Bonsdorff & Pettersson, 1975),  the  nucleocapsid  (N)  protein  (Pettersson  et  al.,  1971)  and  the  L  protein (Ulmanen  et  al.,  1981).  The  cloning  and  sequencing  of  all  three  RNA  segments confirmed that the L RNA encodes the RNA polymerase (Elliott et al., 1992) and that the M  RNA was  a  precursor  for  glycoproteins  Gn  and  Gc  (Rönnholm  &  Pettersson, 1987) and that  the S RNA encodes  the N protein and a non‐structural  (NSs) protein (Simons  et  al.,  1990).  The  virus  RNA  was  shown  to  be  non‐infectious  (Ranki  & Pettersson,  1975).  Thus,  it  was  concluded  that  UUKV  represents  a  new  class  of segmented,  negative‐stranded  RNA  viruses.  Based  on  these  findings,  UUKV  was classified as  a new member of  the  family Bunyaviridae  (Murphy et al.,  1973). UUKV strain  S23 was  for  long  time  the  only  fully  sequenced  UUKV  strain.  Now  there  are other sequences available as well, e.g. the Precarious point virus (Major et al., 2009). Several isolates do exist, the virus has been found in Central and Eastern Europe, e.g. in  former  Czechoslovakia,  Hungary,  Poland,  and  former  USSR  (reviewed  in  Saikku, 1974).  These  reports  are  mainly  from  1960s,  and  the  viruses  were  isolated  from 






Since the early 1970s, for more than four decades, UUKV has served as one of the models to study cellular and molecular biology of bunyaviruses, and general cell biology.  As  a  non‐pathogenic  member  of  the  family,  it  has  been  a  very  convenient model since UUKV can be studied  in biosafety  level 2  laboratories,  instead of  level 3 and 4 laboratories required for highly pathogenic members of the family.   
1.4 Genome organization of bunyaviruses   The  genome  of  UUKV  and  other  known  bunyaviruses  consists  of  three segments  of  single‐stranded  RNA,  named  L  (large),  M  (medium),  and  S  (small) (Plyusnin et al., 2011). The total size of  the UUKV genome is approximately 11.4 kb, which is one of the smallest genomes among bunyaviruses; bunyaviral genomes vary from 11  to  20  kb  (Elliott,  1990).  The  four  structural  proteins  are  transcribed  using negative‐sense strategy (Figure 1). The L segment encodes the viral RNA‐dependent RNA polymerase (RdRp; L protein), the M segment encodes the precursor for the two envelope  glycoproteins  (Gn  and  Gc),  and  the  S  segment  encodes  the  nucleocapsid protein  (N)  (Schmaljohn  &  Nichol,  2007).  In  addition,  the  UUKV  encodes  a  non‐structural protein (NSs protein) from the S segment in the positive‐sense orientation (Simons et al., 1990). The viral RNA segments possess two types of regions: coding regions,  i.e.  the ORFs encoding viral proteins, and non‐coding regions (NCRs). The NCRs  include  the conserved  5'  and  3'  termini  of  the  RNA  segments,  and  also  more  variable  NCRs between  the  termini  and  the  coding  region.  The  5'  and 3'  termini  of  the  three RNA segments  are  complementary  to  each  other,  and  are  thus  able  to  form  stable panhandle‐like  structures  by  base  pairing  (Schmaljohn  &  Nichol,  2007).  The  first evidence for base pairing and forming of closed, circular RNAs was shown for UUKV using electron microscopy  (Pettersson & von Bonsdorff, 1975; Hewlett  et al.,  1977). These  5'  and  3'  termini  of  the  vRNA  and  cRNA  segments  contain  signals  for  the encapsidation of the N protein and regulation of the RNA segments (discussed also in sections 1.5.2 and 1.7.2).  






Tospovirus.  Besides  terminal  NCRs,  in  the  S  segment  there  is  an  intergenic  region (IGR)  located  between  the  N  and  NSs  ORFs.  This  75  nt  long  sequence  is  rich  with adenines (A) and uracils (U), and is predicted to form stem‐loop or hairpin structures, involved in transcription termination (Simons & Pettersson, 1991).                              






There  is  a  great  variety  of  coding  strategies  for production of  non‐structural proteins within  the  family Bunyaviridae.  Tospoviruses  and  phleboviruses,  including UUKV,  encode  NSs  protein  by  similar  ambisense  coding  strategy,  although  the  NSs protein  of  tospoviruses  is  much  larger,  more  than  50  kDa.  Orthobunyaviruses  and some  hantaviruses  encode  small  NSs  proteins  on  the  S  segment  in  positive‐sense coding  strategy, with an overlapping ORF with N protein, whereas nairoviruses and other  hantaviruses  are  not  known  to  encode  any  non‐structural  proteins  in  the  S segment (Elliott & Blakqori, 2011; Plyusnin et al., 2011). The UUKV NSs protein,  as  the name already  suggests,  has not  been  found  in virions (Simons et al., 1992). The function(s) of NSs protein remain(s) still unknown. For  the RVFV NSs protein,  it was  suggested  that  the S  segment and  the NSs protein could have a role in attenuation and virulence (Vialat et al., 2000). Indeed, it was later confirmed that  the NSs protein acts as an  interferon antagonist (Bouloy et al., 2001; Billecocq et al., 2004). The NSs protein was shown to inhibit the transcription of host mRNAs,  including  IFN‐β  mRNA,  and  to  downregulate  of  protein  kinase  R  (PKR)  to prevent host  innate antiviral  functions (Ikegami  et al., 2009). Although the PKR was shown  to  be  the main  factor  for  the  antiviral  activity  of  IFN  against  RVFV,  the  NSs proteins of the less virulent Sandfly fever Sicilian and La Crosse viruses had no such anti‐PKR activity. This may explain the pathogenicity of the RVFV (Habjan et al., 2009).  
1.4.2 M segment and the glycoproteins Gn and Gc   The 3229 nt long UUKV M segment encodes the glycoprotein precursor, p110, which  is post‐translationally  cleaved,  resulting  in  glycoproteins Gn  (70 kDa)  and Gc (65  kDa)  (Kuismanen,  1984;  Rönnholm  &  Pettersson,  1987;  Överby  et  al.,  2007a). UUKV  Gn  and  Gc  glycoproteins  are  well  characterized  type  I  trans‐membrane proteins, which form heterodimers in the endoplasmic reticulum (ER) (Andersson et 






cytoplasmic tails of both the Gn and Gc proteins are involved in efficient virus particle generation (Överby et al., 2007a; Överby et al., 2007b). The cytoplasmic tails of Gn/Gc were shown to be involved in virus entry and morphogenesis also in BUNV (Shi et al., 2007),  where  the  interaction  of  Gn  cytoplasmic  tail  with  RNPs  was  suggested  to launch the virus assembly.  In addition to glycoproteins, some viruses in Orthobunyavirus, Phlebovirus and 
Tospovirus  genera  encode  also  non‐structural  (NSm)  protein  from  the  M  segment using negative‐ or ambisense coding strategy (Schmaljohn & Nichol, 2007; Plyusnin et 
al., 2011). For BUNV, the NSm is encoded with the glycoproteins (Gn‐NSm‐Gc), and the protein colocalizes with Gn/Gc in the Golgi complex. The function of the NSm protein is  unknown,  but  a  VLP‐study  on  BUNV  showed  that  it  is  required  for  the  virus assembly  (Shi  et  al.,  2006).  For  the  RVFV,  the  NSm  protein  was  shown  to  be dispensable  for  the virus  replication  in cell  culture  (Won  et al., 2006; Gerrard  et al., 2007), and the NSm protein was shown to possess an antiapoctotic function (Won et 
al., 2007), first time shown for a phlebovirus protein.  






1.5 Replication cycle of bunyaviruses   The  viral RNA genomes  (vRNA) of  bunyaviruses  are mainly  organized  in  the negative  sense  (‐)  orientation,  e.g.  in  complementary  orientation  compared  to positive‐sense  (+) mRNA  (Schmaljohn & Nichol,  2007).  Positive‐strand RNA  viruses code  for  their  genetic  information  in  the  same  orientation  as mRNA  (+).  Therefore these vRNAs can be directly used as templates for translation in the beginning of the replication  cycle.  In  contrast,  vRNAs  of  bunyaviruses  are  not  infectious,  and  must therefore  be  transcribed  into  complementary  functional mRNAs  before  initiation  of viral  protein  synthesis.  Since  eukaryotic  cells  are  not  able  to  do  this,  the  necessary components  for  transcription  and  replication  have  to  be  encoded  by  the  virus.  The replication cycle of bunyaviruses takes place in the cytoplasm instead of the nucleus of the  infected  cells, which  is  typical  for DNA  viruses.  RNA  splicing  occurs  only  in  the nucleus;  therefore  the  cellular  splicing  machinery  cannot  be  used.  The  majority  of negative‐strand  viruses  replicate  in  the  cytoplasm  with  the  exception  of orthomyxoviruses (including  influenza viruses) and bornaviruses, which replicate  in the nuclei (Fauquet et al., 2005; Schmaljohn & Nichol, 2007). The principal stages of the bunyavirus replication cycle are described in Figure 2. These steps are similar to those  of  other  enveloped,  negative‐strand  RNA  viruses  (Fauquet  et  al.,  2005; Schmaljohn & Nichol, 2007).  
1.5.1 Attachment and entry 







was  identified recently on  the surface of dermal dendritic cells  (DCs), which are  the first to encounter incoming viruses during viral infection. The receptor, DC‐SIGN, is a C‐type lectin, highly expressed on the surface of dermal DCs. This receptor binds the viruses  directly  via  interactions  with  N‐glycans  on  the  viral  glycoproteins  and  is required  for  virus  internalization  and  infection  (Lozach  et  al.,  2011).  After internalization, the viruses separated from DC‐SIGN. The viruses are then transported to  late  endosomes,  where  the  viral  RNPs  and  polymerase  are  released  into  the cytoplasm.  






strategy,  the primary transcription would presumably result  first only  the N protein synthesis.  Based  on  this  hypothesis,  the  gene  encoding  the  NSs  protein  would  be transcribed  from  vRNA  via  cRNA  to  mRNA.  Early  studies  on  UUKV  supported  this hypothesis,  since  during UUKV  infection,  the N  protein was  detected  at  4‐6  h  post‐infection, whereas the NSs protein was observed later, ca. 8 h post‐infection (Ulmanen 
et al., 1981; Simons et al., 1990). However, a study on RVFV showed that both the N and NSs genes from the ambisense S segment are transcribed during the initial stages of  primary  transcription  due  to  the  presence  of  complementary  RNA  copies  in  the virus particles (Ikegami et al., 2005). The transcription of the bunyaviral vRNAs and cRNAs terminates prior to the 5' end of the template RNAs. In UUKV, this results in mRNA transcripts which all are approximately  100  nt  shorter  than  the  corresponding  vRNAs  (Simons  et  al.,  1990; Simons and Pettersson, 1991) and, therefore, in contrast to the vRNAs, unable to form panhandle structures and to circularize. The mRNAs of UUKV and other bunyaviruses are  not  polyadenylated  (Ulmanen  et  al.,  1981;  Schmaljohn  and  Nichol,  2007). Transcription  termination  signals  have been  identified  for BUNV S  segment 5' NCR, and  similar  motifs  are  probably  present  throughout  the  S  segments  of  the  same 
Orthobunyavirus genus (Barr et al., 2006). Ambisense S segment of UUKV contains the 75  nt  long  intergenic  non‐coding  region  between  the  N  and  NSs  ORFs,  which  is probably involved in transcription termination (Simons & Pettersson, 1991). The primary transcription results in the synthesis of mRNAs. The polymerase must then switch to the replicative stage and begin the synthesis of full‐length cRNA templates,  which  then  in  turn  serve  as  templates  for  formation  of  new  vRNA.  This means that  the generation of  truncated mRNAs must be stopped, a process which  is probably  regulated  by  some  viral  or  host  factors  (Schmaljohn & Nichol,  2007).  It  is likely  that  continuous  protein  synthesis  and  especially  production  of  N  protein  is required for the replication of the genome. This requirement has been described for many other viruses and the genome encapsidation by the N protein seems to act as an antitermination signal, resulting in full‐length genome (cRNA) synthesis (Schmaljohn & Nichol,  2007).  Like  in  other Bunyaviridae members, UUKV Gn, Gc,  and N proteins accumulate in the Golgi complex, where the virus particles mature. Virus particles are formed  by  budding  the  RNPs  through  the  Gn‐  and  Gc‐containing  Golgi  membranes (Kuismanen  et  al.,  1982;  Gahmberg  et  al.,  1986).  After  budding  into  the  Golgi cisternae, virions are  transported  to  the cell  surface within  large vesicles (Lozach  et 




























Figure 2. Replication cycle of bunyaviruses. Steps in the infectious cycle are:   1. Attachment of virions to cell‐surface receptors mediated by an interaction of one or both of the integral viral glycoproteins with host receptors. 2. Entry  and  uncoating,  via  receptor‐mediated  endocytosis  followed  by membrane  fusion, allowing viral nucleocapsids and RdRp access to the cytoplasm. 3. Primary transcription, e.g.  the synthesis of mRNA species complementary to the genome templates  by  the  virion‐associated  polymerase  using  host‐cell  capped  primers  (”cap‐snatching”). 4. Translation  of  primary  S,  M  and  L  segment  mRNAs  by  ribosomes,  and  primary glycosylation  of  envelope  proteins,  and  co‐translational  cleavage  of  a  glycoprotein precursor to yield GN and GC. 5. Synthesis  and  encapsidation  of  antigenome  (viral‐complementary)  RNA  to  serve  as templates for genomic RNA, or in some cases, subgenomic mRNA. 6. Genome replication. 7. Secondary  transcription  of  mRNA  from  newly  synthesized  genomes  and  of  ambisense mRNAs from cRNA. 8. Morphogenesis,  including accumulation of GN and GC  in the Golgi,  terminal glycosylation, acquisition of modified host membranes, generally by budding into the Golgi cisternae. 9. Fusion of cytoplasmic vesicles with the plasma membrane and release of mature virions. 






1.6 Reverse genetics systems  Reverse  genetics  systems  can  be  defined  as  techniques  or  tools, where  viral RNA genomes are modified using cDNA copies  in order to understand the effects on the viral phenotype, or the role of specific genome sequences (Bouloy & Flick, 2009; Frias‐Staheli et al., 2011). The reverse genetics systems can be categorized into three different  kind  of  techniques:  full‐length  clone  systems,  minigenome  systems,  and virus‐like  particle  (VLP)  systems.  When  a  full‐length  copy  of  the  viral  genome  is within  the  cDNA,  reverse  genetics  systems  can  be  used  for  the  generation  of recombinant viruses entirely from cDNA (full‐length or infectious clone systems, also called as rescue of the virus). In minigenome and virus‐like particle (VLP) systems the cDNA  encodes  for  some  regions  of  the  viral  genome,  these  systems  facilitate  the modeling of various parts of the virus replication cycle to study the molecular biology of NRSV (Walpita and Flick, 2005; Bouloy and Flick, 2009; Hoenen et al., 2011). The genomic RNA of NSRV is not infectious in itself; an infectious virus particle must deliver its own RdRp into the infected cells to start the RNA replication, and then the RNA must be encapsidated with the N protein (Palese et al., 1996). These features have made  the generation of  infectious viruses with  transfection with viral RNAs  in mammalian  cells  impossible.  On  the  contrary,  the  genomes  of  positive‐strand  RNA viruses  can  serve directly  as  templates  to direct  the  synthesis of  viral proteins. The first successful infectious virus clone was generated completely from cDNA copies of a positive‐strand RNA virus, poliovirus, in the 1980s (Racaniello & Baltimore, 1981).  For NSRV, the first reverse genetics system was established for the influenza A virus  (Luytjes  et  al.,  1989;  Enami  et  al.,  1990).  In  this  classical minigenome  system approach, a cDNA encoding the CAT reporter gene was cloned between the 5' and 3' terminal  viral  NCRs.  Transcription  of  these  constructs  using  T7  RNA  polymerase yielded  chimeric  vRNAs,  able  to  form  RNP  complexes  with  the  N  protein.  After transfection to eukaryotic cells chimeric viruses were generated, which contained the virus‐like RNA encoding CAT in addition to the eight influenza vRNAs. However, this system was based on helper‐virus  infection, which also necessitates strong selection systems to separate the helper viruses from the modified ones.  Minigenome  systems  have  been  established  for  many  viruses  in  the 






this allows the production of VLPs, which is a more convenient tool to study e.g.  the packaging and assembly of the virus particles. The first VLP‐systems for bunyaviruses were developed for BUNV (Shi et al., 2006) and UUKV (Överby et al., 2006). In BUNV VLP‐system  the  role  of  the  NSm  protein  was  studied  in  virus  assembly  and morphogenesis, whereas in the UUKV VLP‐system the focus was on the contributions of  the  glycoproteins  Gn  and  Gc  in  assembly,  packaging  and  budding  of  the  virus (Överby et al., 2006; Överby et al., 2007a; Överby et al., 2007b).  In addition to studying the assembly of virus particles,  the generation of VLP can  lead to  important applications, such as VLP vaccines. The VLP‐system generated for RVFV  (Habjan  et al.,  2008) was also  successfully adapted  for developing a RVFV VLP  vaccine,  which  was  shown  to  be  highly  immunogenic  and  it  protected  mice against RVFV infection (Näslund et al., 2009). In another study with RVFV (Pichlmair 








1.7 The structure and functions of nucleocapsid (N) 
protein  
1.7.1 Structure of the virion 
  UUKV  and  other  bunyaviruses  consist  of  four  structural  proteins:  the glycoproteins  Gn  and  Gc,  the  N  protein,  and  the  L  protein  (Schmaljohn  &  Nichol, 2007). Virions are generally spherical with a diameter ranging from 80 to 120 nm, for UUKV, virions are pleiomorphic and approximately 90‐100 nm in diameter (Saikku et 
al., 1970; Överby et al., 2008). The  two glycoproteins, Gn  and Gc,  are  embedded  in  a  lipid bilayer  envelope, which  is  acquired  from  the host Golgi membranes,  or occasionally  from cell  surface membranes,  where  the  viruses mature  (Pettersson  & Melin,  1996).  The  Gn  and  Gc proteins are organized as  spike‐like projections of 5  to 10 nm on  the  surface of  the virion (Persson & Pettersson, 1991; Rönkä et al., 1995; Överby et al., 2008). These two glycoproteins are  responsible  for  the attachment of  the virus  to  the  target  cells  and they also determine the structure of the viral particles. Some of the UUKV particles are ordered  on  an  icosahedral  lattice,  with  T  =  12  triangulation:  this  arrangement was first  time  observed  for  a  virus  with  UUKV  (Överby  et  al.,  2008).  Similar  structures were reported also for the RVFV (Freiberg et al., 2008; Huiskonen et al., 2009). Inside the  virion,  the  RNA  segments,  i.  e.  the  genome  of  the  virus,  are  individually encapsidated by the N protein, and these RNPs are also associated with the L protein (Plyusnin et al., 2011).  






each  segment  (Hewlett  et  al.,  1977;  Elliott  et  al.,  1992).  The  N  protein  is  the most abundant  protein  in  the  infected  cells  and  virions  in  bunyaviruses  (Schmaljohn  & Nichol, 2007). The N protein binds to the RNA protecting  it  from degradation and is also involved in replication as part of the functional RNP template. In addition, the N protein  interacts  with  the  polymerase  and  the  glycoproteins  during  the  infectious cycle.  The  interaction  between  UUKV  Gn/Gc  and  the  N  protein  was  showed  in coimmunoprecipitation  studies  (Kuismanen,  1984),  which  suggested  that  the cytoplasmic tails of the glycoproteins may interact with the N protein to facilitate the packaging of the RNPs into virus particles. At least one copy of each of the S, M and L ribonucleocapsids must be packaged in a virion particle to make it infectious. For UUKV, it was observed that the average molar ratio of the three UUKV RNPs in the virions was 2:4:1 for S, M, and L segments (Pettersson & Kääriäinen, 1973; Pettersson et al., 1977). Similar ratios were observed also  in  infected  cells  (Ulmanen  et  al.,  1981).  In  addition  to  negative  sense  vRNAs, UUKV encapsidates some S segment cRNA molecules in a 1:10 ratio (cRNA:vRNA) to the  virus  particles  particles  (Simons  et  al.,  1990).  Small  amounts  of  positive‐sense cRNA  have  also  been  found  in  the  virions  of  other  phleboviruses  and  tospoviruses using ambisense coding strategy (Schmaljohn & Hooper, 2001).  The N protein remains associated with RNA throughout  the replication cycle. Several  studies  have  investigated  the  N‐RNA  interactions,  showing  that  N  protein preferentially  binds  with  the  vRNA,  while  there  is  no  obligatory  encapsidation sequence.  This  has  been  shown  for  BUNV,  where  the  N  protein  was  shown  to preferentially bind to the 5' end, most specifically to the nt 1‐33 in the NCR (Osborne & Elliott,  2000).  The  encapsidation  signal  for  the BUNV N protein was  shown  to  be located in the 5' NCR also in another study; and in addition, the 5' NCR was suggested to  possibly  contain  a  region  responsible  for  RdRp  recognition  (Ogg  &  Patterson, 2007).  In  another  study  on  BUNV,  each  N  protein  molecule  was  shown  to  bind approximately  12  nt  of  the  RNA,  while  here  it  was  shown  that  N  protein  does  not require a specific sequence or structure for RNA encapsidation (Mohl & Barr, 2009).   












1.7.4 Solved N protein structures of negative-strand RNA viruses   Recently,  the  progress  in  cryo‐electron  tomography,  microscopy  and crystallization  techniques  has  allowed  researchers  to  solve  many  of  the  previously unknown  N  protein  and  RNP  structures  (Ruigrok  et  al.,  2011).  3D  structures  were solved  for  many  viruses,  e.g.  the  rabies  and  vesicular  stomatitis  viruses (Rhabdoviridae)  (Green  et  al.,  2006;  Albertini  et  al.,  2006),  the  Borna  disease  virus 
(Bornaviridae)  (Rudolph  et  al.,  2003),  and  the  influenza A  virus  (Ye  et  al.,  2006),  of which the majority are important pathogens. There  is  a  great  variation  in  the  structures  of  RNPs.  For  segmented bunyaviruses (Raymond et al., 2010; Ferron et al., 2011), arenaviruses (Hastie et al., 2011a; Hastie  et  al.,  2011b)  and  influenza virus  (Ye  et  al.,  2006),  the  structures  are more flexible than in more helical RNPs of non‐segmented viruses. When the RNPs of rhabdoviruses (Ge et al., 2010), filoviruses (Bharat et al., 2011), and paramyxoviruses (Liljeroos  et  al.,  2011)  are  packaged  into  virus  particles,  they  form  ordered,  tightly packaged  helices,  which  give  the  characteristic  shape  for  the  virions.  Moreover, viruses of  the Bunyaviridae  family do not encode a matrix protein, while  it has been shown  for  non‐segmented  viruses  that  a  matrix  protein  is  required  for  the  RNP packaging, e.g. in Ebola virus  (Noda et al., 2006), influenza virus (Nayak et al., 2004), and measles  virus  (Iwasaki  et  al.,  2009).  A  recent  study  on  the measles  virus  (MV) showed  that  the  matrix  protein  forms  helices  coating  the  helical  RNP,  which  form tightly packed bundles inside the virions (Liljeroos et al., 2011). This kind of matrix‐nucleocapsid  complex  has  not  been  described  previously,  but  since  other paramyxoviruses and NSRV tend to form helical stuctures,  it may well be a common feature of the paramyxoviruses (Liljeroos et al., 2011). The N proteins  of most  of  these  viruses  form  ring‐like  structures, where  the RNA  is  bound  inside  the  rings.  The  N  protein  of  respiratory  syncytial,  rabies,  and vesicular stomatitis viruses form ring‐shaped RNPs, composed of 10 to 11 N protein molecules (Albertini et al., 2006; Green et al., 2006; Tawar et al., 2009) whereas the N protein  of  Borna  disease  virus  crystals were  observed  as  tetramers  (Rudolph  et  al., 2003). The nucleoprotein of  the  influenza virus  forms trimers (Ye et al., 2006; Ng et 







The N‐terminal arm of the N protein was found to be crucial for RNA‐binding in both viruses. For the LASV N protein, a specific gating mechanism was a key feature in the presented model (Hastie et al., 2011b). In this study, it was suggested that the RNA‐free N protein trimer is unable to bind RNA, but after a conformational change, a shift  of  the  N‐terminal  arm  from  the  N  protein  core,  the  RNA‐binding  cavity  is revealed.  Ferron et  al.  (2011) presented  a hexameric  ring  structure  for  the RVFV N protein with proposed sites  for RNA‐binding and oligomerization.  In  contrast  to  the first  structure  (Raymond  et  al.,  2010),  which  presented  the  RVFV  N  protein  as  a globular protein,  the N‐terminal  arm of  the RVFV N protein was  extended  from  the molecule core exposing the RNA‐binding cavity in the central part of the protein. Even though the N protein of RVFV was capable of oligomerization without RNA, Ferron et 
al.  (2011)  suggested  that  the  association  with  RNA  may  be  required  for  the stabilization of the N protein oligomers. The N protein structure of the nairovirus CCHFV was recently solved with 2.3 Å  resolution  (Guo  et  al.,  2012).  The  N  protein  structure  was  described  as  “racket‐shaped” with distinct “head” and “stalk” domains, with no resemblance with other N proteins reported so far from other NSRV. Furthermore, the CCHFV N protein showed DNA‐specific endonuclease activity for which the head domain was responsible (Guo 






2. AIMS OF THE STUDY  
 The specific aims of this study were:   
• to  analyze  the  role  of  the  non‐coding  regions  (NCRs)  and  to  compare  the promoter  strengths of UUKV S, M and L RNA  segments,  and  to  analyze  the role of the intergenic region (IGR) of the UUKV S (small) RNA segment.   
• to investigate the oligomerization ability of the UUKV N protein and identify the domains involved in N protein oligomerization.    








3. MATERIALS AND METHODS   This  section  describes  briefly  the materials  and methods  used  in  this  study. More detailed descriptions can be  found  in the original publications, which are here referred to by their Roman numerals (I‐III).  
3.1 Materials  
3.1.1 Virus (I, II)   The origin and  isolation of  the Uukuniemi virus (Oker‐Blom  et al., 1964) and the isolation and preparation of the UUKV prototype strain S23 have been described earlier (Pettersson & Kääriäinen, 1973). The virus stock was originated from a single virus  plaque.  The  titer  of  the  UUKV  stock  used  in  this  study  was  1  ×  108  plaque‐forming units (PFU)/ml.  
3.1.2 Cell lines (I, II, III)   Adherent cell  lines were originally obtained  from the American Type Culture Collection (ATCC). Four mammalian cell lines (BHK‐21, BSR, COS‐7 and HeLa) and one insect  cell  line  (Sf9)  were  used.  BHK‐21  cells  (Baby  hamster  kidney  [Mesocricetus 










3.1.3 Antibodies and antisera (II, III)   The UUKV‐N protein was detected with mouse monoclonal (MAbs) and rabbit polyclonal antibodies (PAbs) (II, III). Three different MAbs, prepared at the Karolinska Institute  in  the  1990s  (R.  F.  Pettersson,  unpublished  data)  were  used  in  the immunofluorescence  analysis.  Polyclonal  antibodies  were  used  in  immunoblotting: two of them were also prepared at the Karolinska Institute in 1990s (J. F. Simons & R. F.  Pettersson,  unpublished data)  and one  antibody  against  the UUKV N protein was from  a  commercial  source  (ProSci  Inc.).  The UUKV N  fusion  proteins  and  the DNA‐binding  (DNA‐BD)  and  DNA‐activation  (DNA‐AD)  domains  expressed  in  the  M2H‐assay (II, III) were detected using MAbs against GAL4 DNA‐BD and/or VP16 DNA‐AD domains  (SC‐510  and  SC‐7545,  Santa Cruz Biotechnology).  The  following  secondary polyclonal  antibodies  were  used  in  the  studies:  horseradish  peroxidase  (HRP) conjugated  rabbit  anti‐mouse  IgG/HRP  (P0161,  DakoCytomation),  and  swine  anti‐rabbit  IgG/HRP  (P0217,  DakoCytomation),  and  fluorescein  isothiocyanate  (FITC) conjugated  swine  anti‐rabbit  IgG/FITC  (F0205,  DakoCytomation),  and  rabbit  anti‐mouse IgG/FITC (F0261, DakoCytomation).  
3.2 Methods  
3.2.1 Construction of plasmids (I, II, III)   The plasmids were  constructed using  standard  recombinant DNA  techniques (Sambrook & Russell, 2001).   






CAT)  (Flick  &  Pettersson,  2001)  and  pHL2823  (pCMV‐EGFP)  (R.  Flick  &  G.  Hobom, unpublished), and flanked by the UUKV NCRs from the 5' and 3' termini of the S and L segments. These expression cassettes – containing the reporter gene and UUKV NCRs – were cloned in between the BbsI and BsmBI restriction enzyme sites in the plasmid pRF108. This cloning strategy generated constructs which could be transcribed by the RNA pol I system in the nuclei of eukaryotic cells, generating transcripts without any end modifications or additional  foreign nucleotides at  the ends of  the minigenomes. To  drive  the  pol  I  transcription  and  replication  of  these  chimeric  RNAs,  plasmids expressing  UUKV  L  and  N  proteins  under  the  cytomegalovirus  (CMV)  promoter (pCMV‐UUKV‐L and pCMV‐UUKV‐N)  (Flick & Pettersson, 2001) were used when  the cells were co‐transfected.  
3.2.1.2 UUKV N protein mutant plasmids: (II, III)  The UUKV N protein ORF was derived from plasmid pGEM‐3N (Simons et al., 1992) containing  the complete wild  type (wt) UUKV N protein cDNA. The N protein ORF  was  amplified  using  Pfu  DNA  polymerase  (Fermentas)  and  cloned  into pcDNA3.1(+)  plasmid  (Invitrogen),  resulting  in  the  construct  pcDNA‐UUKV‐N encoding  the  full‐length  N  protein.  The  N  protein  ORF  was  also  cloned  into  the plasmids used  in  the M2H‐assay: plasmids pM1 and pVP16,  containing DNA‐BD and DNA‐AD domains  (BD Biosciences  Clontech)  respectively,  resulting  in  plasmids  pM‐UUKV‐N and pVP‐UUKV‐N.  Two types of mutations were introduced to the N protein ORF: larger N‐ and C‐terminal  truncations  and  single  and double  aa mutations  (Figures 2  and 3  in  II). N‐ and C‐terminal truncations to N protein ORF (II) were introduced by oligonucleotide‐directed  mutagenesis  using  primers  carrying  HindIII/XbaI  restriction  sites.  Amino acid  substitutions  to  alanines  (II,  III)  (Table  2) were  introduced by  oligonucleotide‐directed mutagenesis, using a site‐directed mutagenesis kit (Stratagene) according to the manufacturer’s instructions.  






3.2.3 2D and 3D predictions and analysis of UUKV N and 
phlebovirus N proteins (II, III)   Molecular weight  (MW)  and  theoretical  pI were  calculated  using  the  Expasy ProtParam program (Gasteiger et al., 2005). Secondary structure predictions of UUKV N  protein  (II,  III)  were  performed  using  the  servers:  Jpred (http://www.compbio.dundee.ac.uk/~www‐jpred/)  (Cole  et  al.,  2008),  PsiPred (http://bioinf.cs.ucl.ac.uk/psipred)  (Buchan  et  al.,  2010)  and  PredictProtein (http://www.predictprotein.org/) (Rost et al., 2004).  The  tertiary  structure  of  the  N  protein  was  predicted  using  the  Robetta server’s  ab  initio  modeling  (http://robetta.bakerlab.org/)  (Bonneau  et  al.,  2002; Raman et al., 2009) and later modeled using the RVFV N protein (PDB code: 3OV9) as a  template  with  the  servers:  I‐Tasser  (http://zhanglab.ccmb.med.umich.edu/I‐TASSER) (Roy et al., 2010), Phyre2 (http://www.sbg.bio.ic.ac.uk/phyre2) (Kelley and Sternberg,  2009)  and  Swissmodel  (http://swissmodel.expasy.org/workspace) (Arnold et al., 2006). The multiple sequence alignments of the UUKV N and phlebovirus N proteins were  generated  using  the  ClustalW2  program  (http://www.ebi.ac.uk/clustalw)  and the  aa  sequences,  multiple  alignments,  and  secondary  structure  of  UUKV  N  were visualized using the ESPript program (http://espript.ibcp.fr/ESPript).   
3.2.4 RNA secondary structure prediction (I)   RNA  secondary  structures  were  predicted  using  the  GeneBee  program (http://www.genebee.msu.su/services/rna2_reduced.html).   








3.2.5.1 Transfections and superinfection with UUKV (I)   BHK‐21  and  BSR  cells  were  transfected  with  different  UUKV  minigenome plasmids  and with  the  plasmid  pHL2823  containing  eGFP  under  the  control  of  the CMV promoter (R. Flick & G. Hobom, unpublished data) to determine the efficiency of transfection. Transfections were performed as described earlier (Flick et al., 2002). At 24 h post‐transfection, cells were cultivated to 50‐80% confluency and superinfected with UUKV (multiplicity of infection from 1 to 3). Cells were infected for 1 h (at 37°C under 5% CO2 atmosphere),  after which  the virus‐containing medium was  removed and replaced with a cell culture medium containing 5% FCS and antibiotics.  
3.2.5.2 Passaging of recombinant UUKV (I)   For  passaging  the  recombinant  UUKV,  BHK‐21  cells  were  transfected  and superinfected  as described  above.  Cells were  analyzed  for  reporter  gene  expression 72 h post‐infection and  the supernatants were used  for passaging  the virus  in  fresh BHK‐21  cells.  Infection  was  performed  as  described  above,  and  the  cells  were incubated for 72 h. Passaging was repeated as long as the passages were successful.  
3.2.5.3 Transfections (II, III)   BHK‐21  cells  were  transfected  with  three  plasmids:  the  UUKV  M  segment‐based minigenome plasmid (UUKV M‐CAT), which contains the CAT reporter gene and plasmids expressing the viral polymerase: (pCMV‐UUKV‐L) (Flick & Pettersson, 2001) and N protein (wt or mutated pcDNA‐UUKV‐N). The transfected cells were incubated for 48 h and analyzed for reporter gene CAT activity.  
3.2.5.4 Chloramphenicol acetyltransferase (CAT) assay (I, II, III)   The  CAT  assays  were  performed  as  described  earlier  (Flick  and  Pettersson, 2001)  and  according  to  the  manufacturer's  instructions  (Flash Cat Kit; Molecular 






lysed  by  three  freeze‐thaw  cycles.  The  clarified  cell  lysates  were  mixed  with  the fluorescent  chloramphenicol  substrate  and  acetyl  coenzyme  A. After  2  to  4  h incubation  at  37°C,  the  reaction  products  were  separated  by  thin‐layer chromatography  (TLC)  whereupon  the  CAT  expression  was  visualized  by  UV illumination.  The  CAT  expression  levels  between  different  samples  were quantitatively compared to each other and to controls in each assay.    
  






3.2.6 Virus-like particle (VLP) -system for UUKV (II, III)   VLP  infection was performed as described earlier  (Överby  et al.,  2006b). For the VLP  infection,  BHK‐21  cells were  first  transfected with  four  plasmids:  the  same three  plasmids  as  used  in  the minigenome  system —  UUKV M‐CAT,  pCMV‐UUKV‐L (Flick & Pettersson, 2001), and wt or mutated pcDNA‐UUKV‐N: and in addition pCMV‐UUKV‐Gn/Gc expressing the glycoproteins from the UUKV M segment. The supernatants  from these transfected cells (VLP passage) were transfered to  new  BHK‐21  cells,  which  were  transfected  24  h  prior  to  the  VLP  passage  with pCMV‐UUKV‐L and wt pcDNA‐UUKV‐N to support minigenome expression. After 1 h incubation the inoculum was replaced with fresh medium and cells were analyzed for CAT activity 48 h post‐infection.  
3.2.7 Mammalian two-hybrid (M2H) -assay (II, III)   The  M2H‐assay  was  used  to  investigate  the  N  protein  interactions,  and  the details  are  described  in  publications  II  and  III.  Briefly,  HeLa  cells  were  transfected with  four  plasmids:  two  plasmids  expressing  the  full‐length  or  mutated  N  protein fused to the DNA‐BD and DNA‐AD domains (plasmids pM‐UUKV‐N and pVP‐UUKV‐N), and  two  reporter  plasmids  expressing  the  firefly  (FL)  luciferase  and  renilla  (RL) luciferase  (Promega).  The  reporter  gene  activities  were  determined  24  h  post‐transfection with  the Dual‐Luciferase Reporter Assay System (Promega). Each assay was tested in triplicate and all experiments were performed at least twice, most of the experiments  three  times.  The  RL  values  were  used  to  measure  the  transfection efficiency and to normalize the FL values. The normalized value for each experiment was calculated as following: [RL (wt N‐N interaction)/RL (mutated N‐N interaction) × (FL (mutated N‐N intercation]. The formula for comparing the wt N‐N and mutated N‐N  interaction  was  calculated  as  following:  [(Normalized  value  of  the  mutated  N‐N interaction/normalized value of the wt N‐N interaction) × 100].  
3.2.8 Immunofluorescence assay (IFA) and UV microscopy (I, II, III)  






were  fixed with 4% paraformaldehyde,  and GFP expression was visualized using an Axioplan 2 microscope (Zeiss) and inverted fluorescence microscopy (Eclipse TE 300, Nikon). For  fluorescence‐activated cell  sorting  (FACS) analysis  (FACSCalibur; Becton Dickinson), the cells were trypsinized before being fixed. 
 
3.2.8.2 Immunofluorescence assay (IFA) (II)   BHK‐21  cells  were  grown  on  coverslips  and  transfected  with  wt  or  mutant pcDNA‐UUKV‐N constructs or infected with UUKV, when the medium was replaced 1 h after the infection. At 24 h post‐transfection or UUKV infection, cells were fixed with 3.5%  paraformaldehyde.  BHK‐21  cells  without  transfection/infection  were  used  as negative  controls.  For  the  detection  of  N  protein  using  fluorescence  microscopy, coverslips were incubated with a mixture of two UUKV‐N MAbs (30 min), followed by FITC‐conjugated rabbit anti‐mouse IgG antibodies (Dako) (30 min) and images were collected with Axioplan 2 microscope (Zeiss).  
3.2.9 Chemical cross-linking (II)   COS‐7  cells were  transfected with  pcDNA‐UUKV‐N  constructs  using  FuGene6 transfection  reagent  (Roche  Applied  Science)  according  to  the  manufacturer’s instructions. Cells were lysed at 24 h p. i., and lysates were cross‐linked using 0.1 and 0.5 mM bis[sulfosuccinimidyl] suberate (BS3) (Thermo Fisher Scientific) for 30 min at RT, following detection of the N proteins by immunoblotting.   








4. RESULTS AND DISCUSSION 
 
4.1 Analysis of the non-coding regions (NCRs) of UUKV 
RNA segments (I)   The aim of the study was to evaluate the role of the non‐coding regions (NCRs) of UUKV RNA segments in transcription, replication and packaging.  In bunyaviruses, all three RNA segments (L, M and S) carry non‐coding regions in the termini of the segments. The NCRs are composed of highly conserved and more variable  regions.  The  conserved,  genus‐specific  sequences  at  the  extreme  5'  and  3' termini  are  complementary  to  each  other  and  are  able  to  form  stable  panhandle structures by base pairing  (Figure 4). This  leads  to  the  formation of  closed,  circular RNAs,  observed  in  all  three  RNA  segments  of  UUKV  (Pettersson  &  von  Bonsdorff, 1975; Hewlett  et al., 1977). Between the conserved regions  in  the NCR and the ORF coding for the viral genes, there is a variable non‐coding region. These regions vary in length in between the segments of the same virus and between the viruses of the same genus  (Schmaljohn  &  Nichol,  2007).  The  variable  regions  contain  cis‐acting  signals, which are involved in regulation of transcription and replication of the viral segments, and  contain  signals  for  the  encapsidation  of  the  RNAs  with  N  protein  (Osborne  & Elliott, 2000) and for the packaging of the RNA segments into virus particles (Flick et 
al., 2002). In addition to these terminal NCRs, UUKV carries a non‐coding,  intergenic region (IGR) in the ambisense S segment. This 75 nt long sequence, located in between the N and NSs gene ORFs contains signals for transcription termination.      
 






4.1.1 Generation of the UUKV minigenome constructs   For studying the role of the NCRs, a total of 24 minigenomes were generated. These minigenomes contained the reporter genes (CAT and GFP) flanked by the 5' and 3' NCRs of the UUKV S and L segments, and the cDNA inserts were inserted in between the RNA pol I promoter and terminator sequences of the vector plasmid (Figure 5, and Figure  1  in  I).  The  minigenomes  were  analyzed  using  the  RNA  pol  I  ‐based  UUKV reverse genetics  system  (Flick  et  al.,  2002; Flick & Pettersson, 2001) and  compared with  the M  segment minigenome  constructs, which were  generated  in  the  previous study (Flick et al., 2002). The reporter genes were  introduced  in the antisense (‐) orientation for  the L segments constructs and in both the antisense (‐) and sense (+) orientation for the S segment,  mimicking  the  ambisense  coding  strategy  for  the  N  and  NSs  genes, respectively.  Twelve  minigenomes  are  shown  in  Figure  5:  these  constructs  were designed to study and compare the promoter activities of the terminal NCRs and role of the IGR of the S segment. After these analyses, the other 12 constructs (Figure 6 and Figures 6 and 7 in  I), were designed to examine further the terminal NCRs of the three RNA segments.   













The analysis of these four S segment minigenomes showed that the constructs were  functional,  and  resulted  in  reporter  gene  expression.  This  confirmed  that  the terminal NCRs of the S segment RNA contain all of the regulatory elements needed for the  encapsidation,  replication  and  transcription  of  the  UUKV  S  segment.  In  the negative controls, where the N and L expression plasmids were excluded, no reporter gene activity was observed.  The comparison of the promoter activities of the S segment showed that there is  no  difference  between  the  5'  and  3'  vRNA  promoter  strengths.  The  levels  of  the reporter gene activities were similar between constructs where the N and NSs genes were  replaced with  expression  genes,  either  by  CAT  [pRF287  and  pRF289]  or  GFP [pRF288 and pRF290] (Figure 3 in I). The results demonstrated that the transcription start  signals  for  the  N  and  NSs  genes  were  equally  strong.  This  finding  was  quite surprising,  because  it was presumed  that  activity  of  the N  gene promoter would be stronger, since the N protein is the most abundant protein found in the infected cells. Even if the number of the transcripts would be similar, it results in different amounts of  N  and  NSs  proteins  during  the  UUKV  infection.  This  could  be  explained  by  the different nature of the mRNAs and also proteins, e.g. the stability of the NSs mRNA and protein may be much weaker than that of the N protein.  






The  expression  of  the  reporter  genes  from  the  IGR‐containing minigenomes was  higher  than  in  the  minigenomes  without  IGR  which  was  observed  in  the antisense‐  and  sense‐orientated  constructs  and  in  both  the  CAT  and  GFP minigenomes.  This  strong  increase  in  the  reporter  gene  expression  levels was  even higher  in  the GFP expressing  constructs  compared  to  the CAT expression  (Figure 5, and  figure 3  in  I). Based on  these results,  it  can be concluded  that  inserting  the  IGR sequence  downstream  of  the  ORF  improves  the  expression  of  the  UUKV  S  segment based minigenomes  and  that  the  cis‐acting  signals  located within  the  IGR  terminate transcription of the N and NSs genes.  
4.1.4 Comparison of promoter activities within NCRs of three 






protein in UUKV infected cells. The M segment NCR as the most efficient promoter of the  three RNA  segments,  followed  by  the  L  and  S  segments, was  also  shown  in  the other bunyavirus, BUNV (Barr et al., 2003), thus supporting the data presented here. On the contrary, a study with RVFV (Gauliard et al., 2006) indicated that the strengths of  the promoters within  the NCRs were  in  the order L > S > M, whereas  the  level of genome  segment  transcription  and  replication  in  infected  cells  is  almost  in  the opposite order (S > M > L). These results can be partly explained by the length of the RNA  segment,  which  probably  influences  the  viral  gene  expression,  as  exhibited  in influenza viruses (Azzeh et al., 2001). Longer segments require stronger promoters to drive the transcription and replication of the viral genes. This would explain that the L and M segment promoters were the strongest in all three studies on UUKV, BUNV, and RVFV.  Other  explanation  is  that  the  differences  of  the  promoter  strengths  are probably  due  to  specific  sequences  and/or  structures  within  the  NCRs,  and  these sequences differ between species. These regulatory elements interact with the L and N proteins, and therefore could influence the transcription and the encapsidation of the RNA  segments.  Indeed,  it was  shown  for  influenza  virus  promoters  that  the  5′  NCR determines  the  binding  of  the  polymerase,  whereas  the  3′  NCR  influences  the transcription initiation (Li et al., 1998). On the other hand, for BUNV it was shown that the  5′  and  3′  termini  do  not  act  independently  but  form  together  a  functional promoter  (Barr & Wertz,  2004). Hence,  it  seems  to be  that  there  is  variation  in  the promoter strengths between different viruses and no generalization can be made.   













































  In  order  to  study  whether  promoter  strength  could  be  restored,  point mutations were  introduced  into  the NCRs  of  chimeric minigenomes  to  increase  the number of potential base pairs within the last 20 nt in the 5′ and 3′ termini. Six UUKV minigenomes were generated and analyzed: pRF426 and pRF427 [S/M], pRF430 and pRF431 [S/L], and pRF432 and pRF433 [L/S] (Figure 7 in I). Indeed, by elevating the level  of  base  pairing  by  exchanging  and/or  deleting  nucleotides  in  the  termini,  the promoter strengths could be restored  for  the 5′  termini, which  led  to more efficient minigenome expression. In contrast, the 3′ NCR tolerated much less mutations while it was observed that promoter efficiency could not be restored by elevating the level of base  pairing.  In  conclusion,  this  data  confirmed  that  base  pairing  between  the terminal  nucleotides  of  the  non‐conserved  NCRs  is  needed  for  the  efficient transcription and replication of viral RNAs.  
4.1.6 Packaging of the minigenomes and passaging of recombinant UUKV  The functionality of the minigenomes was analyzed in order to show whether the  minigenomes  can  be  packaged  into  infectious  UUKV  particles  and  passaged  to fresh  cell  cultures.  The  cells  were  co‐transfected  with  the  S,  M  and  L  segment minigenomes and the N protein and polymerase expression plasmids. The cells were superinfected with the UUKV 24 h post‐infection to provide the packaging machinery for  the  minigenome  packaging.  The  minigenomes  from  all  three  segments  were successfully  passaged once  (Figure 5  in  I),  observed  as  a  successful  transfer  of  CAT activity to the fresh cells.  The  differences  between  three  RNA  segments  were  observed:  the  M  and  S segment  based minigenomes  showed  a  rapid  decrease  in  reporter  gene  levels,  and after three passages, only weak CAT activities were detected for pRF200 and pRF301, whereas no CAT activity was reported for the pRF312. This decrease in the reporter gene  activity  was  probably  due  to  the  competition  between  the  minigenome  RNA segments and the RNA segments of wt UUKV used in the superinfection, which leads to more  efficient  packaging of  the wt  virus.  Similar  data  on  the  loss  of  the  reporter gene activity in serial passaging have been reported for the influenza virus (Luytjes et 






In  conclusion,  this  study  showed  that  passaging  of  artificial  UUKV  vRNAs  to progeny UUKV particles is dependent on the cis‐acting signals located within the NCRs in the RNA segments. Clear differences were observed in the packaging efficiency: the L  segment  vRNA  was  packaged  most  efficiently,  followed  by  the  M  segment  and  S segment genes, in which artificial NSs vRNA was more efficiently packaged than the N vRNA. Whether there are other, additional cis‐acting signals for packaging within the UUKV coding regions, remains to be determined.  Two  recent  studies  elucidated  the  role  of  the  RVFV  NCRs  (Murakami  et  al., 2012)  and  packaging  of  the  RNPs  (Terasaki  et  al.,  2011)  using  VLP‐systems.  In  all three RVFV RNA segments, 25 nt  from the 5′  termini NCR were shown to be equally competent  for  RNA  packaging.  These  regions  carried  RNA  packaging  signals, which overlapped with the RNA replication signal (Murakami et al., 2012). In addition, it was shown with L  segment deletion mutants  that  truncated L RNA, but not  full‐length L RNA, were efficiently packaged. It was further suggested that the L RNA may require compaction  of  RNA  segment  for  efficient  packaging  (Murakami  et  al.,  2012).  In another study on the copackaging of the RNA segments (Terasaki et al., 2011), it was proposed that the M RNA works as a central regulator for the packaging of the S and L RNAs  into  the  virion.  The M RNA was  suggested  to  have  two RNA elements,  one  of which interacts with L segment and the other with S segment, and these interactions would  facilitate  the  copackaging  of  three  RNAs  into  virus  particles.  It  was  also suggested  that  M  RNA  functions  cooperatively  with  the  S  RNAs  and  that  these coordinated  functions  are  important  for  efficient  L  RNA  packaging  (Terasaki  et  al., 2011).  In  the  light  of  these  data  on  RVFV,  it  would  be  interesting  to  see  whether similar mechanisms and functions could be found also from the UUKV RNA segments.  
 
4.2 Functional analysis of Uukuniemi virus nucleocapsid 
(N) protein: roles in oligomerization (II) and RNA binding 






4.2.1 Bioinformatic analysis on UUKV N protein (II, III)   Since  there  were  no  solved  N  protein  3D  structures  from  the  Bunyaviridae family  in  the  beginning  of  these  studies,  the  work  was  initiated  by  performing bioinformatic analysis on the UUKV and other phlebovirus N proteins. The secondary structure (2D) of the UUKV N protein was predicted using the Jpred, Psipred and PredictProtein servers (Buchan et al., 2010; Cole et al., 2008; Rost 
et al., 2004). These analyses predicted that the N protein (254 aa residues, molecular weight of of 28.5 kD), is a compact, globular protein mainly formed of α‐helices. The first predictions suggested that the N protein is formed of 13 to 15 α‐helices (Figure 2 in II). The following structural predictions refined the number of α‐helices to 11 to 13. To  evaluate  whether  secondary  structures  are  conserved  throughout  the 





















Figure 7. Multiple sequence alignment of phlebovirus N proteins. Conserved aa residues are shown  in white  on  red  background,  invariant  residues  in  red  on white  backround  and  the variable residues in black on white backround. The UUKV N protein aa residues which were mutated are marked with blue dots ()  for the putative RNA‐binding residues, and triangles ()  for the oligomerization mutants. The viruses and GenBank accession numbers for the N protein  sequences  are: Uukuniemi  virus  [GI 38371708],  SFTS virus  [GI 325209540],  Corfou virus  [GI  146336856],  Toscana  virus  [GI  52627074],  Candiru  virus  [GI  328545956],  Punta Toro virus  [GI 127918], Aguacate virus  [GI 330850814],  Frijoles virus  [GI 146336850],  and Rift Valley fever virus [GI 87622293]. 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Toscana_virus            M        A                     Y G                          D    I   R I LAF S I VN FA Q FD KRIVQ V E G KK VK M VL.. SDENY D LDESAD GT NAW E P L K R TAK...GRDW M
Candiru_virus            M        A                     Y G                          D    I   E L VDI A I VQ FA Q FD KRVME L E G VE AK M IL.. S...Y K AGHEID DT KAW A A L V R ......GDDW Q
Punta_Toro_virus         M        A                     Y G                          D    I   E I VQF E V VT FA Q FD KRVIA V D G KQ VK M VL.. S...Y E ASESID QT AGW D A L K R ......GEDW K
Aguacate_virus           M        A                     Y G                          D    I   E L IEF I V VN FA Q FD KRVLE L Q G QE AR M VL.. AD..F R SEAGVN AD VNW E A L Q R ......GSSW K
Frijoles_virus           M        A                     Y G                          D    I   A I IAF N V VN FA E FN QRIIQ V E G QT VK M VL.. TD..Y D AGEPIN AE MGW E A L Q K ......PQTW M
Rift_Valley_fever_virus   M        A                     Y G                          D    I   Q L IQF R I VR FA Q FD RRVIE L Q G EK AK M VL.. DN..Y E AAQAVD NE EQW E A L R Y ......GADW K
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SFTS_virus_SD24         L RGNK        S  G      L   Y L          T  R        T            V   T    VKA KM S SK L A Q K  VE A R I V VAQS P  AAA L LP A I SG N R M E G R ET LS P L TW C AA KEY GP
Corfou_virus            L RGNK        S  G      L   Y L          T  R        T            V   T    KKM RM E AK V A V K  VE K R L T VAAA A  QAI V LP A P QE P E K A K G PG NG L L GW V EV ENF PG
Toscana_virus           L RGNK        S  G      L   Y L          T  R        T            V   V    EAM KM K AS V N I V  KE N R I S VSAA V  QAL L LP N P MK E I A S Q G PG DT L F PW V RV SES SG
Candiru_virus           L RGNK        S  G      L   Y L          T  R        T            V   T    SKM KM K KK V A V R  KE N R L S VTAA A  QAT V LP C P MV E I Q K S G PS DD L L GY C EY EEF TG
Punta_Toro_virus        L RGNK        S  G      L   Y L          T  R        T            V   T    NKM KM K KA V E V K  KS N R L S ITAA A  QAA V LP S P IL D M N L K G PS DD L F GW C DY QEY TG
Aguacate_virus          L RGNK        S  G      L   Y L          T  R        T            V   T    EKM KM E KK V A K K  KS N R L S VAAA A  QAL V LP A I IL E T L K Q G PG DD L L GW C PH ENF TG
Frijoles_virus          L RGNK        S  G      L   Y L          T  R        T            V   T    SKM KM E KK A R I I  KS N R L S IAAA A  QAL L LP A P IE A K S T G G PG DD L F GW C AT HPY TG
Rift_Valley_fever_virus  L RGNK        S  G      L   Y L          T  R        T            V   T    RRM KM E KA V A I K  KE N R L S VAAA A  QAL L LP A P MM K T E N K G PS DE L L GW C VV SEW TG
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SFTS_virus_SD24          M        P   M   F                   A  L    F   IN   R             AV N KV Y M A GSLI V TL   Q A TKT   G K EV NSF DL .EN PE CM PTAG TEATTK ME YS W D VKM AS T Y R
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Toscana_virus            M        P   M   F                   A  L    F   IN   R             TT D IA Y M S AGII L TI   M E SKT   T A EV ATF KA GVT RA HP DLD. PNGAGA AD HG F I PSL KQ N A E
Candiru_virus            M        P   M   F                   A  L    F   IN   R             KN D LS Y M S AGLI L TI   M Q SRT   G V EV STF RD .KN RA HP DPK. PPDVLS CD FS F V PRN LS S A D
Punta_Toro_virus         M        P   M   F                   A  L    F   IN   R             RA D IS Y M S AGLI L EI   M Q SKT   G K EI SSF RA .SS RA HP DQE. PADVFS TQ HC F I PSL LS D V E
Aguacate_virus           M        P   M   F                   A  L    F   IN   R             EA D LS F L S AGLV L AI   L Q SKV   G K EV ASF QA .PG RC HP DTT. PPETQD LA HS F V PSL KP G V K
Frijoles_virus           M        P   M   F                   A  L    F   IN   R             AA D IS Y M S AGLI I VV   L Q SRV   G K VV SSF QA .PG RA HP DNS. PEAYLQ VD HA Y L RNM QP S V L
Rift_Valley_fever_virus   M        P   M   F                   A  L    F   IN   R             TT D LS Y M S AGMV L AI   L Q SRV   G K EV ATF QG .PA RH HP DPS. PEDYLR LD HS Y L PNL RT E A T
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Candiru_virus             A     F         L                   A                              P  AMNS  I RK  N IL N Q SNPV AA KVFRIN S SGEQ SF R LG DE M P K GLK..
Punta_Toro_virus          A     F         L                   A                              P  AISS  L RR  T II N K SSST SA KVFRMQ T TSAN AM K LG ND L P V SL...
Aguacate_virus            A     F         L                   A                              P  AVNG  I RR  S VV N V SEAV VA NKFRML G GPDK KM Q LG DV G P K SSQ..
Frijoles_virus            A     F         L                   A                              P  AIVS  I RR  A IV N K TAAV SA KAFMMN G SNDR KM M FG DQ G P E TAV..






4.2.2 Robetta ab initio 3D predictions for UUKV N protein    In  addition  to  2D  predictions  and  sequence  alignment  analyses  of  the  N protein,  a  3D  modeling  approach  was  chosen  to  get  further  insights  into  the  N protein’s  properties.  Since  there  were  no  solved  N  protein  3D  structures  from  any virus  within  the Bunyaviridae  family  at  the  time  of  this  study,  and  no  homologuos structures  for  UUKV  N  were  found,  most  of  the  3D  prediction  programs  could  not predict structure for the UUKV N protein. Hence, another approach was chosen. The Robetta protein structure prediction server (http://robetta.bakerlab.org) (Bonneau  et  al.,  2002)  using  the ab  initio method was  used  to  analyze  the UUKV N protein  in  detail.  This  server parses protein  chains  into putative domains,  and  then further models these domains either by homology or by ab initio (also called de novo) modeling,  which  refers  to  structural  prediction  using  nothing  more  than  first principles (i.e. physics). The server predicted ten UUKV N protein models, which were analyzed to locate putative domains or aa residues involved in the oligomerization of N protein, and to model RNA‐binding surfaces or aa residues in the N protein. Most of the  Robetta  predictions  suggested  the N  protein  to  adopt mostly  the α‐helical  fold; some of the models showed the N protein as a compact, globular protein, whereas in other  models  the  shape  of  the  protein  was  more  elongated.  The  UUKV  N  protein Robetta  models  were  used  to  define  the  mutagenesis  strategy.  One  of  the  Robetta models is shown in Figure 8A.   
4.2.2.1 Predictions for studying the N protein oligomerization (II)   One  of  the  N  protein  models  was  examined  more  closely  to  study  the oligomerization  of  the  UUKV  N  protein  (Figure  3B  in  II).  Studies  on  other bunyaviruses have  shown  that  the  terminal  regions of  the N protein are needed  for the oligomerization of the RVFV, BUNV, and Tula hantavirus, and that the N‐terminal part has an  important  role  (Alminaite  et al., 2008; Kaukinen  et al., 2003). Therefore the study was focused on the terminal regions of the UUKV N protein, and particularly to the N‐terminal part.   






form a positively charged surface, able to bind the negatively charged nucleic acid. In most of  the predicted UUKV N Robetta models, a cleft was observed  in between  the protein  domains.  Models  with  a  cavity  or  groove  in  the  central  part  of  the  protein were favored in selecting the potential aa residues for the mutational analysis, since for many negative‐strand viruses,  such  structures were  shown  to bind nucleic  acids (Ruigrok et al., 2011). The UUKV N protein sequence shows that the N‐terminal part of the  protein  is  rich  with  the  positively  charged  aa  residues  (R  &  K),  often  found involved  in  the RNA‐binding  domains  in many  negative‐strand  viruses.  This  region, rich in positively charged aa residues, was located in the central cavity of the protein in  most  of  the  models.  One  of  the  Robetta  models,  which  was  used  to  guide  the selection of putative RNA‐binding residues for mutational analysis, is shown in Figure 8A. Based on  the UUKV N protein 2D and 3D analysis using  these  two methods,  the phlebovirus N  protein  alignments  and Robetta ab  initio  predictions  on  the UUKV N protein, a set of aa residues were chosen for the mutagenesis to investigate the role of these aa residues in oligomerization and RNA‐binding.  
4.2.3 Functional analysis of the N protein deletion mutants in 
M2H- and minigenome assays (II)  






The mutagenesis study was more focused on the N–terminus of the N protein, since earlier study on RVFV (Le May et al., 2005) showed that the N‐terminal part of N protein,  and  especially  the  hydrophobic  aa  residues within  the  first α‐helices, were important for the N‐N interaction. Since these two phlebovirus N proteins are likely to fold in a similar manner, the N‐terminal region of UUKV N protein was targeted with site‐directed  mutagenesis.  The  first  two  predicted  α‐helices  (aa  1‐33)  contained numerous aromatic and hydrophobic residues (Figure 3A in II). The Robetta 3D model of these two N‐terminal α‐helices (Figures 3B and 3C in II), showed that residues W7, F10,  I14,  W19,  I24,  F27,  and  F31  could  form  a  specific  structure,  with  a  shared hydrophobic  space  between  the  α‐helices,  which  is  not  exposed  to  the  solvent.  A conformational change in the N protein could open the N‐terminal structure, enabling hydrophobic  and  aromatic  aa  residues  to  form  an  N‐N  interaction  with  another  N protein molecule.  A  set  of  eight  point mutations was  generated  to  evaluate  the  contribution of the  N‐terminus  in  forming  N‐N  interactions:  W7A,  F10A,  I14A,  W19A,  I24A,  F27A, F31A, and Y33A (Figure 3A  in  II). For  the C‐terminal part,  and especially  the  last C‐terminal α‐helix of the N protein, only a few conserved aa residues within the last C‐terminal were found based on 2D structure predictions and sequence alignments. To determine whether the last C‐terminal α‐helix is involved in the N‐N interactions, two mutations  were  introduced:  R251A,  where  R  was  found  well  conserved  in  all phleboviruses,  and  the  double  mutant  QQ244‐245AA  for  evaluation  of  the involvement of the polar side chains in the N‐N interaction (Figure 3A in II).  
4.2.3.2 Analysis of the impact of N- and C-terminal deletions to UUKV N 






Next, the deletion mutants were tested in the minigenome system established for UUKV (Flick & Pettersson, 2001). In this system, competent N protein is needed for the  formation of oligomers and  the RNPs and  in  the  transcription and replication of the  minigenomes.  Disabling  the  N‐N  interaction  and  oligomerization  should  also prevent  the  minigenome  transcription  and  replication.  All  five  N‐  and  C‐terminal deletions  destroyed  the  functionality  of  the  N  protein  in  the  minigenome  system (Figure 5 in  II) suggesting that both the N‐ and C‐termini of the N protein are needed in the oligomerization process. Another plausible explanation is that truncations, even relatively short ones (e.g. ΔC10), prevent the protein from folding correctly, and also the forming of N‐N interactions.  
4.2.3.3 Functional analysis of the oligomerization point mutations   In M2H‐ and minigenome assays,  the mutations  in  the C‐terminal part of  the protein did not have any effect on the protein functionality (Table 1 and Figure 7 in II). It is very likely that the last C‐terminal α‐helix is not involved in the oligomerization, but has a role in maintaining the overall structure of the N protein. The  results with  the N‐terminal part were  interesting,  since  several  residues were found, where the mutations affected the N protein functionality.  In M2H‐assay, four mutants,  F10A,  I14A,  I24A,  and  F31A,  showed  reduced  N‐N  interaction  ability compared to the wt N‐N interaction, whereas the other four mutations, W7A, W19A, F27A,  and  Y33A,  did  not  affect  the  N‐N  interaction  (Table  3).  In  the  minigenome system, five of the mutations, W7A, I14A, I24A, F27A, and F31A, completely destroyed the N protein  functionality, which was measured by  the  lack of  the CAT expression. Two mutations, F10A and W19A, had a milder impact on the N protein functionality, whereas mutation Y33A functioned similarly to the wt N protein (Table 3, and Figure 7  in  II).  The  expression  of  all  N  protein  mutants  in  both  M2H‐  and  minigenome systems was verified by immunoblotting.   
4.2.3.4 Analysis of the point mutations in the virus-like particle (VLP) system 
 In the first publication (I), the NCRs of three UUKV RNA segments were studied using the minigenome system established for UUKV (Flick & Pettersson, 2001; Flick et 






the  components  are  fully  functional,  this  leads  to  the  generation  of  minigenome‐containing  VLPs.  When  the  generated  UUK‐VLPs  are  released  into  the  cell supernatant,  they  are  able  to  infect  new  cells. Without  a  competent N protein,  both packaging and infectivity functions are inhibited or abolished. In  the  negative  control  for  VLP‐infected  cells  (without  UUKV‐L  or  UUKV‐Gn/Gc), no CAT activity was detected, whereas the positive control containing UUKV‐Gn/Gc, UUKV‐L and wt N showed strong CAT activity (Table 3 and Figure 7 in II). Six N‐terminal  point  mutations  (W7A,  I14A,  W19A,  I24A,  F27A,  and  F31A)  showed reduced CAT expression, indicating that the N protein was affected and not capable of oligomerizing  and/or  encapsidating  the minigenome  RNA  (Figure  7  in  II).  Three  of these mutants, I14A, I24A, and F31A, were not competent either in the minigenome‐ or in the M2H‐assays. The mutations W7A and F27A were altered in the minigenome system  but  showed  strong  N‐N  interaction  in  the  M2H‐system.  With  these  two mutations,  the differences between  the  results  obtained  from  two  systems  could be due to possible involvement of the residues in RNA‐binding. The mutation Y33A acted as  the wt  N  protein  in  the  VLP‐system,  and  the  same was  observed  for  the  two  C‐terminal mutants, R251A and QQ244‐245AA. The results obtained in the VLP‐system were in agreement with those of the minigenome system. This data also showed that in the VLP‐system all the components must be fully functional and less alterations are tolerated than in the minigenome system.  
4.2.3.5 Immunofluorescence microscopy (IFA) of UUKV N protein mutations 






that  some mutations which were harmful  for  the N‐N  interactions,  also  affected  the intracellular localization of the N protein in transfected cells.  
4.2.3.6 The role of N- and C-terminal mutations in UUKV N protein 
oligomerization (II) 

























Table  2.  Summary  of  the  results  on  the  UUKV N  protein  oligomerization  and  RNA‐binding mutants.  The  functionality  of  the  UUKV  N  protein  point  mutants  was  evaluated  in  the minigenome‐, VLP‐ and M2H‐assays. The mutations designed for studying the oligomerization (N‐N interactions) are shown in bold, whereas the mutations targeted for the putative RNA‐binding residues of the UUKV N protein are shown in italics.  
UUKV N protein 
point mutations 
Target of  





M2H % of 
interaction2 
wt N protein  +++ +++ 100 
W7A Oligomerization - - >100  
F10A Oligomerization + + 34±4* 
I14A Oligomerization - - 60±18  
W19A Oligomerization +/++ - >100  
I24A Oligomerization - - 56±12* 
F27A Oligomerization - - >100  
F31A Oligomerization - - 23±5* 
Y33A Oligomerization +++ +++ >100* 
R44A RNA-binding +++ ++ 89±11 
KK50-51AA RNA-binding +++ ++ >100 
R61A RNA-binding - - 82±25 
R64A RNA-binding - - 7±4 
R73A RNA-binding - - 12±6 
K76A RNA-binding ++ + 78±18 
R98A RNA-binding + - 32±19 
R115A RNA-binding - - 18±10 
H178A RNA-binding + - 18±6 
R187A RNA-binding +++ ++ ND 
R194A RNA-binding +++ ++ ND 
K223A RNA-binding - - 3±1 
R224A RNA-binding + - 35±12 
K238A RNA-binding +++ ++ ND 
QQ244-245AA Oligomerization +++ +++ >100* 
R251A Oligomerization +++ +++ 96±11*  
1   In minigenome (and VLP systems) the level of CAT expression ranged between non‐affected (+++), reduced (++), substantially reduced (+), and completely eliminated (‐).  






4.2.4 Functional analysis of UUKV nucleocapsid (N) protein: role in 
RNA-binding (III)  
4.2.4.1 Modeling of potential RNA-binding surfaces of UUKV nucleocapsid 
protein (III)  The aim of the study presented in publication III was to identify the potential RNA‐binding surfaces or aa residues on the UUKV N protein. To find these potential aa residues, bioinformatic analysis was performed to guide  the selection of aa residues for the mutational and functional analysis.  It is known from several other viral proteins that conserved, positively charged aa are involved in RNA‐binding (Ruigrok et al., 2011). Another characteristic feature is that the RNA‐binding protein usually forms a cleft, groove or cavity, which is suitable for  binding  the  RNA  molecules.  This  has  been  demonstrated  for  several  NSRVs (Ruigrok  et  al.,  2011).  The  RNP  formation  plays  an  important  role  in  replication  of NSRV, but  the details of how the N proteins bind  the RNA, have remained unknown until  recently.  Within  the  last  few  years,  several  N  protein  structures  have  been solved, revealing also the mechanism of RNA‐binding for many viruses (Ruigrok et al., 2011). Based on  the phlebovirus N protein alignments  (Figure 7) and predictions of the 3D models of the UUKV N protein (discussed in sections 4.2.2 and 4.2.2.2), a set of positively charged aa residues were chosen as targets for mutagenesis. The resulting set  contained  13  single mutants  and  one  double mutant:  R44A,  KK50‐51AA,  R61A, R64A, R73A, K76A, R98A, R115A, H178A, R187A, R194A, K223A, R224A, and K238A. Some of the mutations were located within, or in the close proximity of the potential RNA‐binding cavity in the predicted UUKV N protein model (Figure 8C). To investigate the  functionality of  these mutants and possible contribution to the RNA‐binding,  the mutants were analyzed using three different systems: minigenome‐, VLP‐, and M2H‐systems.  
 
4.2.4.2 Functional analysis of the RNA-binding mutants using the 












4.2.5 Evaluation of the results with updated UUKV N protein 3D-
models and solved RVFV N protein structures 
 The projects on the UUKV N protein oligomerization (II) and RNA‐binding (III) were started before any bunyaviral N protein structures were solved. In the course of the study, two groups reported the solved N protein structure for RVFV (Raymond et 
al.,  2010;  Ferron  et  al.,  2011),  a  phlebovirus  closely  related  to  UUKV.  In  addition, another bunyavirus N protein, the CCHFV (genus Nairovirus) N structure was solved (Guo et al., 2012). These  two  structures  give  an  insight  for  the  first  time  into  bunyaviral  N proteins. First of all, the N structures seem not to be conserved throughout the genera. This  is  rather  expected,  since  there  is  great  variation  in  the  bunyaviral  N  proteins, even the sizes of  the N proteins range  from 19 kDa  for  the orthobunyaviruses  to 54 kDa for the hantaviruses. The N protein of CCHFV was shown to have an endonuclease activity,  not  described  earlier  for  any  bunyavirus.  Interestingly,  the  head domain  of the CCHFV N protein resembles the topology found in the LASV N protein (Hastie et 







The server used for 
UUKV N protein  
3D prediction 
Z-score RMSD N:o of  
aligned 
positions 






I-Tasser 36.6 1.1 245 253  36 
Phyre2 33.3 1.3 216 254 40 
Swissmodel 39.5 0.1 243 249 36 
Robetta1 1.0 4.0 43 254 2 
Robetta2 1.2 7.6 60 254 16 
Robetta3 2.6 6.9 43 254 22 
Robetta4 0.5 4.8 57 254 11 






















CONCLUDING REMARKS AND FUTURE 
PROSPECTS 
  The first part of this thesis (I) concentrated on the regulation of the Uukuniemi virus  (UUKV)  genome  expression;  the  non‐coding  regions  (NCRs)  of  UUKV  RNA segments  were  analyzed  in  order  to  understand  how  transcription  and  replication machineries of the virus function. A comparison of three RNA segments of UUKV using the  minigenome  system  showed  that  NCRs  carry  all  the  necessary  signals  for  the transcription,  replication  and  packaging  of  the  virus.  The  intergenic  region  (IGR), located between  the N and NSs protein ORFs, was also analyzed  in  the minigenome system  and  it  was  demonstrated  that  this  region  is  essential  for  transcription termination.  When this study was carried out, the minigenome system was the only reverse genetics tool to study the transcription and replication of UUKV. However, since then the techniques have developed, and the VLP‐system was subsequently developed for UUKV, enabling a more sophisticated approach to study the molecular characteristics of  UUKV  and  other  bunyaviruses.  Many  questions  about  bunyavirus  transcription, replication, and encapsidation of the RNAs and co‐packaging the RNPs to the virions remain still open. Moreover, the role(s) of the signaling sequences and NCRs in these processes  requires  further  exploration.  The  discovery  of  new,  pathogenic phleboviruses makes the development of reverse genetics systems for phleboviruses even  more  topical.  The  rescue  of  infectious  UUKV  would  be  an  interesting  step  in developing UUKV  reverse  genetics  systems,  and  all  the  tools  for  this  are  already  at hand. The unique ambisense coding strategy for the UUKV S segment provides also an possibility  to  develope  e.g.  live‐attenuated  vaccines;  it  was  shown  for  RVFV,  a pathogenic  phlebovirus  related  to  UUKV,  that  the  NSs  gene  can  be  replaced  and  a recombinant  virus  containing  only  two  genomic  segments was  generated.  A  similar technique  could  be  adopted  for  UUKV,  which  as  a  non‐pathogenic  member  of  the 
Phlebovirus genus could serve as an safe alternative to the pathogenic RVFV.  The  second  part  of  the  study  focused  on  the  UUKV  N  protein  (II,  III), particularly on its oligomerization (i.e. N‐N interactions) and RNA‐binding (i.e. N‐RNA interactions). The mutational analyses of the N protein showed that both the N‐ and C‐termini of the UUKV N protein are needed for oligomerization, and especially the two 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